Suppr超能文献

重症监护病房中肾移植受者的管理

Management of the kidney transplant recipient in the intensive care unit.

作者信息

Voora Santhi, Shah Sapna, Nadim Mitra K

机构信息

Division of Nephrology and Hypertension, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

出版信息

Curr Opin Crit Care. 2023 Dec 1;29(6):587-594. doi: 10.1097/MCC.0000000000001098. Epub 2023 Sep 26.

Abstract

PURPOSE OF REVIEW

Kidney transplantation is the ideal treatment for patients with chronic kidney disease and end stage renal disease. While centers are performing more transplants every year, the need for organ transplantation outpaces the supply of organ donors. Due to a growing population of patients with advanced kidney disease and a scarcity of kidneys from deceased donors, patients face extended wait times. By the time patients approach transplantation they have multiple comorbidities, in particular cardiovascular complications. Their risk of complications is further compounded by exposure to immunosuppression post kidney transplantation. Kidney transplant recipients (KTRs) are medically complex and may require acute management in the intensive care unit (ICU), as a result of cardiovascular complications, infections, and/or respiratory compromise from lung infections and/or acute pulmonary edema. Acute complication of immunosuppression, such as thrombotic microangiopathy and posterior reversible encephalopathy syndrome may also warrant ICU admission. This review will cover assessment of high-risk complications and management strategies following kidney transplantation.

RECENT FINDINGS

For intensivists caring for KTRs, it is imperative to understand anatomical considerations of the transplanted kidney, unique infectious risks faced by this population, and appropriate modulation of immunosuppression.

SUMMARY

Recognizing potential complications and implementing appropriate management strategies for KTRs admitted to the ICU will improve kidney allograft and patient survival outcomes.

摘要

综述目的

肾移植是慢性肾脏病和终末期肾病患者的理想治疗方法。虽然各中心每年进行的移植手术越来越多,但器官移植的需求超过了器官捐献者的供应。由于晚期肾病患者数量不断增加,以及 deceased 供体的肾脏稀缺,患者面临更长的等待时间。到患者接近移植时,他们已有多种合并症,尤其是心血管并发症。肾移植后接受免疫抑制治疗会使他们的并发症风险进一步增加。肾移植受者(KTRs)病情复杂,由于心血管并发症、感染和/或肺部感染和/或急性肺水肿导致的呼吸功能不全,可能需要在重症监护病房(ICU)进行急性处理。免疫抑制的急性并发症,如血栓性微血管病和后部可逆性脑病综合征也可能需要入住 ICU。本综述将涵盖肾移植后高危并发症的评估和管理策略。

最新发现

对于照顾 KTRs 的重症监护医生来说,了解移植肾的解剖学因素、该人群面临的独特感染风险以及免疫抑制的适当调整至关重要。

总结

识别入住 ICU 的 KTRs 的潜在并发症并实施适当的管理策略将改善肾移植和患者的生存结局。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验